These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Calcitonin for the treatment of osteoporosis: dosage and dosing interval in Japan. Yamauchi H; Suzuki H; Orimo H J Bone Miner Metab; 2003; 21(4):198-204. PubMed ID: 12811623 [No Abstract] [Full Text] [Related]
8. [Treatment of osteoporosis in octogenarians]. Pepersack T Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of osteoporosis with calcitonin]. Nakano T Nihon Rinsho; 2004 Feb; 62 Suppl 2():423-6. PubMed ID: 15035164 [No Abstract] [Full Text] [Related]
10. Osteoporosis into the year 2010. Mundy GR Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():32-7; discussion 37-8. PubMed ID: 8624340 [No Abstract] [Full Text] [Related]
11. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of osteoporosis with antiresorptive drugs]. Vestergaard P; Mosekilde L; Brixen K Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840 [No Abstract] [Full Text] [Related]
13. Mechanisms of action of the bisphosphonates. Fleisch H Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358 [TBL] [Abstract][Full Text] [Related]
14. Issues in designing and testing a "cure" for osteoporosis. Cummings S J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283 [No Abstract] [Full Text] [Related]
15. A role of osteoclasts in the repair process after bone defect with special reference to carbonic anhydrase. Sakai T; Shimazaki M; Chanoki Y; Okuno H; Shimazu A Osaka City Med J; 1986 Dec; 32(2):49-63. PubMed ID: 3114698 [No Abstract] [Full Text] [Related]
16. Osteoporosis: how should it be treated? Odvina CV J Investig Med; 2006 Apr; 54(3):114-22. PubMed ID: 16948394 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of the effect of a Chinese herb medicine on osteoclastic bone resorption. Yu S; Chen K; Li S; Zhang K Chin J Dent Res; 1999 Feb; 2(1):7-11. PubMed ID: 10557176 [TBL] [Abstract][Full Text] [Related]
18. [Bisphosphonates in pharmacotherapy of bone diseases]. Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603 [TBL] [Abstract][Full Text] [Related]
19. [The successful development of bisphosphonates in the therapy of osteoporosis]. Fassbender WJ; Stumpf UC; Kurth A Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363 [TBL] [Abstract][Full Text] [Related]
20. Antiresorptive agents and osteoarthritis: more than a bone to pick? Abramson SB; Honig S Arthritis Rheum; 2007 Aug; 56(8):2469-73. PubMed ID: 17665438 [No Abstract] [Full Text] [Related] [Next] [New Search]